Co-Authors
This is a "connection" page, showing publications co-authored by Kai Duan and Huajun Zhang.
Connection Strength
0.555
-
Reply to Kesici et al. and Zeng et al.: Blocking the virus and reducing the inflammatory damage in COVID-19. Proc Natl Acad Sci U S A. 2020 06 09; 117(23):12529-12530.
Score: 0.220
-
Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc Natl Acad Sci U S A. 2020 04 28; 117(17):9490-9496.
Score: 0.219
-
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial. EClinicalMedicine. 2021 Aug; 38:101010.
Score: 0.060
-
Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials. JAMA. 2020 09 08; 324(10):951-960.
Score: 0.056